These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 12798587)
21. Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial. Di Lorenzo E; Sauro R; Varricchio A; Carbone G; Cortese G; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G; De Luca G Circulation; 2009 Sep; 120(11):964-72. PubMed ID: 19720939 [TBL] [Abstract][Full Text] [Related]
22. Impact of sirolimus-eluting and Paclitaxel-eluting stents on outcome in patients with diabetes mellitus and stenting in more than one coronary artery. Stankovic G; Cosgrave J; Chieffo A; Iakovou I; Sangiorgi G; Montorfano M; Airoldi F; Carlino M; Michev I; Finci L; Colombo A Am J Cardiol; 2006 Aug; 98(3):362-6. PubMed ID: 16860024 [TBL] [Abstract][Full Text] [Related]
23. Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians. Vijayakumar M; Lemos PA; Hoye A; Ong AT; Aoki J; Granillo GR; McFadden EP; Sianos G; Hofma SH; Smits PC; van der Giessen WJ; de Feyter P; van Domburg RT; Cummins PA; Serruys PW Am J Cardiol; 2004 Oct; 94(7):909-13. PubMed ID: 15464675 [TBL] [Abstract][Full Text] [Related]
24. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial. Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698 [TBL] [Abstract][Full Text] [Related]
25. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798 [TBL] [Abstract][Full Text] [Related]
26. Impact of sirolimus-eluting stents on outcomes of patients treated for acute myocardial infarction by primary angioplasty. Cheneau E; Rha SW; Kuchulakanti PK; Stabile E; Kinnaird T; Torguson R; Pichard AD; Satler LF; Kent KM; Waksman R Catheter Cardiovasc Interv; 2005 Aug; 65(4):469-72. PubMed ID: 15988741 [TBL] [Abstract][Full Text] [Related]
27. Type D personality predicts death or myocardial infarction after bare metal stent or sirolimus-eluting stent implantation: a Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry substudy. Pedersen SS; Lemos PA; van Vooren PR; Liu TK; Daemen J; Erdman RA; Smits PC; Serruys PW; van Domburg RT J Am Coll Cardiol; 2004 Sep; 44(5):997-1001. PubMed ID: 15337209 [TBL] [Abstract][Full Text] [Related]
28. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease. Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW; Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019 [TBL] [Abstract][Full Text] [Related]
29. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group. Simonton CA; Brodie B; Cheek B; Krainin F; Metzger C; Hermiller J; Juk S; Duffy P; Humphrey A; Nussbaum M; Laurent S; J Am Coll Cardiol; 2007 Sep; 50(13):1214-22. PubMed ID: 17888837 [TBL] [Abstract][Full Text] [Related]
30. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial. Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029 [TBL] [Abstract][Full Text] [Related]
31. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study. Saia F; Lemos PA; Lee CH; Arampatzis CA; Hoye A; Degertekin M; Tanabe K; Sianos G; Smits PC; McFadden E; Hofma SH; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW Circulation; 2003 Oct; 108(16):1927-9. PubMed ID: 14557354 [TBL] [Abstract][Full Text] [Related]
32. The everolimus-eluting stent in real-world patients: 6-month follow-up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) registry. Onuma Y; Kukreja N; Piazza N; Eindhoven J; Girasis C; Schenkeveld L; van Domburg R; Serruys PW; J Am Coll Cardiol; 2009 Jul; 54(3):269-76. PubMed ID: 19589442 [TBL] [Abstract][Full Text] [Related]
33. Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial. Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G; De Luca G Am Heart J; 2009 Oct; 158(4):e43-50. PubMed ID: 19781402 [TBL] [Abstract][Full Text] [Related]
34. Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents: 5-Year Results From SORT OUT IV. Jensen LO; Thayssen P; Christiansen EH; Maeng M; Ravkilde J; Hansen KN; Hansen HS; Krusell L; Kaltoft A; Tilsted HH; Berencsi K; Junker A; Lassen JF; J Am Coll Cardiol; 2016 Feb; 67(7):751-62. PubMed ID: 26892409 [TBL] [Abstract][Full Text] [Related]
35. Long-term safety and efficacy of second-generation everolimus-eluting stents compared to other limus-eluting stents and bare metal stents in patients with acute coronary syndrome. Omar A; Torguson R; Kitabata H; Pendyala LK; Loh JP; Magalhaes MA; Satler LF; Suddath WO; Pichard AD; Waksman R Catheter Cardiovasc Interv; 2014 Dec; 84(7):1053-60. PubMed ID: 24619969 [TBL] [Abstract][Full Text] [Related]
36. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry. Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K; JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178 [TBL] [Abstract][Full Text] [Related]
37. Very long sirolimus-eluting stent implantation for de novo coronary lesions. Degertekin M; Arampatzis CA; Lemos PA; Saia F; Hoye A; Daemen J; Tanabe K; Lee CH; Hofma SJ; Sianos G; McFadden E; van der Giessen W; Smits PC; de Feyter PJ; van Domburg RT; Serruys PW Am J Cardiol; 2004 Apr; 93(7):826-9. PubMed ID: 15050483 [TBL] [Abstract][Full Text] [Related]
38. Three-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam cardiology hospital-(RESEARCH) registry. García-García HM; Daemen J; Kukreja N; Tanimoto S; van Mieghem CA; van der Ent M; van Domburg RT; Serruys PW Catheter Cardiovasc Interv; 2007 Nov; 70(5):635-9. PubMed ID: 17960629 [TBL] [Abstract][Full Text] [Related]
39. Four-year clinical follow-up of the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital registry. Daemen J; Kukreja N; van Twisk PH; Onuma Y; de Jaegere PP; van Domburg R; Serruys PW Am J Cardiol; 2008 Apr; 101(8):1105-11. PubMed ID: 18394442 [TBL] [Abstract][Full Text] [Related]
40. Long-term results of the randomized comparison of everolimus-eluting stents and sirolimus-eluting stent in patients with ST elevation myocardial infarction (RACES-MI trial). Di Lorenzo E; Sauro R; Capasso M; Lanni F; Lanzillo T; Carbone G; Manganelli F; Palmieri V; Serino V; Pagliuca MR; Rosato G; Suryapranata H; De Luca G Int J Cardiol; 2016 Jan; 202():177-82. PubMed ID: 26397405 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]